greeksoup/ stock research

Chemours (CC) FY2024 results: revenue $5.8 billion, down 4.9% on the year

Chemours Co. (CC) reported revenue of $5.8 billion for fiscal 2024, the year ended 31 December 2024, down 4.9% on the year before. Net income was $69 million, and diluted earnings per share $0.46. The figures are the company's own, from the 10-K it filed with the SEC on 18 February 2025.

Revenue
$5.8 billion
-4.9% on the year
FY2017FY2024
Operating margin
5.7%
-4.0% a year earlier
FY2017FY2024
Net income
$69 million
FY2017FY2024
Diluted EPS
$0.46
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue5,7826,0786,831-4.9%
Cost of revenue4,6314,7765,215-3.0%
Gross profit1,1421,3021,616-12.3%
Gross margin19.8%21.4%23.7%
Research and development109108118+0.9%
Selling, general and administrative5981,286710-53.5%
Operating income328-245772
Operating margin5.7%-4.0%11.3%
Interest expense263208163+26.4%
Pre-tax income106-318741
Income tax37.0-66.0163
Effective tax rate34.9%n/a22.0%
Net income69.0-253578
Net margin1.2%-4.2%8.5%
Diluted EPS$0.46-$1.70$3.65
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow-633556754
Capital expenditure360370307-2.7%
Free cash flow-993186447
Free cash flow margin-17.2%3.1%6.5%
Cash from investing-353-229-284
Cash from financing-36.0172-685
Depreciation and amortisation292309291-5.5%
Share-based compensation15.018.027.0-16.7%
Buybacksn/a69.0495
Dividends paid148149154-0.7%
Dividend per share$1.00$1.00$1.000.0%
Diluted shares, weighted150m149m158m+0.8%
Shares outstanding at period end149m149m149m+0.6%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity5717211,107-20.8%
Non-controlling interest1.02.0n/a-50.0%
Debt4,1134,0383,633+1.9%
Operating lease liabilities198208198-4.8%
Finance lease liabilities38.046.049.0-17.4%
Other liabilities2,5943,2362,653-19.8%
Total liabilities and equity7,5158,2517,640-8.9%
Fixed assets3,1833,2073,171-0.7%
Goodwill46.0102102-54.9%
Intangible assets3.03.013.00.0%
Cash and equivalents7131,2031,102-40.7%
Receivables619509509+21.6%
Inventory1,4631,3491,404+8.5%
Other assets1,4881,8781,339-20.8%
Total assets7,5158,2517,640-8.9%

10-K for the year ended 31 December 2024, filed 18 February 2025: the filing.